CD44 and breast carcinoma: A study using the inflammatory breast cancer cell line SUM149, found that ALDEFLOUR+ cells comprised approximately 5% of the total cell population, and of this ALDEFLOUR+ population, 13% of cells were CD44+/CD24−, compared to only 3% in ALDEFLOUR- cells.